Back
Distillate Small/Mid Cash Flow ETF Vs. Kymera Therapeutics Industry Stock Comparison
Buy
74
DSMC
Distillate Small/Mid Cash Flow ETF
Last Price:
36.51
Seasonality Move:
16.88%
Buy
62
KYMR
Kymera Therapeutics
Last Price:
46.30
Seasonality Move:
65.72%
Buy
74
Distillate Small/Mid Cash Flow ETF (DSMC)
is a Buy
Is Distillate Small/Mid Cash Flow ETF a Buy, Sell or Hold?
- The current Distillate Small/Mid Cash Flow ETF [DSMC] share price is $36.45. The Score for DSMC is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- DSMC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $46.41. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DSMC Stock Price Chart
What is Distillate Small/Mid Cash Flow ETF's stock price today?
-
The Distillate Small/Mid Cash Flow ETF share price today is $36.45
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSMC is experiencing slight selling pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.
DSMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.32 | Buy |
Relative Strength Index (14 RSI): | 61.37 | Buy |
Chaikin Money Flow: | -507 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (35.38 - 36.18) | Buy |
Bollinger Bands (100): | (34.31 - 36.07) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.2 | Sell |
Relative Strength Index (14 RSI): | 51.28 | Buy |
Chaikin Money Flow: | 22833 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.9 - 49.54) | Sell |
Bollinger Bands (100): | (35.01 - 48.01) | Buy |
DSMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.09 | Buy |
20-day SMA: | 35.88 | Buy |
50-day SMA: | 35.2 | Buy |
200-day SMA: | 35.1 | Buy |
8-day EMA: | 36.18 | Buy |
20-day EMA: | 35.85 | Buy |
50-day EMA: | 35.47 | Buy |
200-day EMA: | 34.57 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.1 | Buy |
20-day SMA: | 46.53 | Sell |
50-day SMA: | 46.23 | Buy |
200-day SMA: | 38.73 | Buy |
8-day EMA: | 45.83 | Buy |
20-day EMA: | 45.9 | Buy |
50-day EMA: | 45.24 | Buy |
200-day EMA: | 38.58 | Buy |
Distillate Small/Mid Cash Flow ETF Earnings Growth & DSMC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
Distillate Small/Mid Cash Flow ETF Technical Analysis
Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 17 | Oct 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |